Impact of routine pediatric varicella vaccination on the epidemiology of herpes zoster;Impact de la vaccination de routine de l'enfant contre la varicelle sur l'épidémiologie du zona

Medecine et Maladies Infectieuses

Volumn 39, Issue 9, 2009, Pages 698-706

  Alain, S ^a   Paccalin, M ^b   Larnaudie, S ^c   Perreaux, F ^d   Launay, O ^e  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Service de vaccination   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

^e INSERM   (France)

Author keywords

Chicken pox; Epidemiology; Shingles; Vaccination; VZV

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

CHICKENPOX; CHILD HEALTH; HERPES ZOSTER; HUMAN; INCIDENCE; MATHEMATICAL ANALYSIS; MEDICAL LITERATURE; REVIEW; UNITED STATES; VACCINATION;

CHICKENPOX VACCINE; HERPES ZOSTER; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 70349487524     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2009.04.009     Document Type: Review

References (52)

1. Bonmarin I., Ndiaye B., Seringe E., and Levy-Bruhl D. Epidémiologie de la varicelle en France. Bull Epidemiol Hebd 8 (2005) 30-32
2. Heininger U., and Seward J.F. Varicella. Lancet 368 (2006) 1365-1376
3. Hanslik T., Blanchon T., and Alvarez F.P. Vaccination des adultes contre la varicelle et le zona. Rev Med Int 28 (2007) 166-172
4. Khoshnood B., Debruyne M., Lançon F., Emery C., Fagnani F., Durand I., et al. Seroprevalence of varicella in the French population. Pediatr Infect Dis J 25 (2006) 41-44
5. Hope-Simpson R.E. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med 58 (1965) 9-20
6. Arvin A.M. Varicella-Zoster virus. In: Fields B.N. (Ed). Virology. (1996), Lippincott-Raven, Philadelphia 2547-2585
7. Marin M., Güris D., Chaves S.S., Schmid S., and Seward J.F. Prevention of varicella. Recommendations of the Advisory Committee on Immunization practices (ACIP). MMWR 56 RR-4 (2007) 1-40
8. Chaves S.S., Santibanez T.A., Gargiullo P., and Guris D. Chickenpox exposure and herpes zoster disease incidence in older adults in the US. Public Health Reports 122 (2007) 155-159
9. Yawn B.P., Saddier P., Wollan P.C., St Sauver J.L., Kurland M.J., and Sy L.S. A population based-study of the incidence and complication rates of herpes zoster before zoster vaccine introduction. Mayo Clin Proc 82 (2007) 1341-1349
10. Solomon B.A., Kaporis A.G., Glass A.T., Simon S.I., and Baldwin H.E. Lasting immunity to varicella in doctors study (LIVID study). J Am Acad Dermatol 38 (1998) 763-765
11. Terada K., Yoshihiro K., Kawano S., and Morita T. Incidence of herpes zoster in pediatricians and family practitioners. Estimation of efficacy of varicella vaccine for protection against herpes zoster in the elderly. Kawasaki Med J 20 (1994) 99-102
12. Thomas S.L., Wheeler J.G., and Hall A.J. Contacts with varicella or with children and protection against herpes zoster in adults: a case-control study. Lancet 360 (2002) 678-682
13. Brisson M., Gay N.J., Edmunds W.J., and Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 20 (2002) 2500-2507
14. Czernichow S., Dupuy A., Flahault A., and Chosidow O. Herpes zoster: incidence study among sentinel general practitioners. Ann Dermatol Venereol 128 (2001) 497-501
15. Perry C.M., and Bryson H.M. Oka/Merck varicella vaccine. Clin Immunother 4 (1995) 396-416
16. Pinot de Moira A., and Nardone A. Varicella zoster virus vaccination policies and surveillance strategies in Europe. Euro Surveill 10 (2005) 43-45
17. Ramet J. A new challenge for Europe: introducing a pediatric quadrivalent vaccine for measles, mumps, rubella, and varicella. Int J Infect Dis 11 Suppl. 2 (2007) S49-55
18. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. JAMA 287 (2002) 606-611
19. Ministère de la Santé, de la Jeunesse et des Sports. Groupe de travail du Comité technique des vaccinations. Recommandations vaccinales concernant la varicelle. Séance du 05 juillet 2007. 77 pages. Accessible sur : www.hcsp.fr/hcspi/explore.cgi/hcsp049r20070816_Vari celle.pdf. Dernier accès le 17 septembre 2008.
20. Calendrier vaccinal 2009. Avis du Haut conseil de la santé publique. Bull Epidemiol Hebd 2009;16-17:129-48, 45-62. http://www.invs.sante.fr/beh/2009/16_17/index.htm
21. Breuer J. Commentary on varicella vaccination of children in the United States: Assessment after the first decade 1995-2005. J Clin Virol 33 (2005) 96-98
22. Brisson M., Edmunds W.J., and Gay N.J. Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV. J Med Virol 70 (2003) S31-S37
23. Comité consultatif national de l'immunisation (CCNI). Une déclaration d'un comité consultatif (DCC). Mise à jour sur la varicelle. Relevé des maladies transmissibles au Canada (RMTC) 2004; 30(DCC-1):1-26.
24. Committee on Infectious Disease. Prevention of varicella: recommendations for use of varicella vaccines in children including a recommendation for a routine 2-dose varicella immunization schedule. Pediatrics 2007; 120:221-31.
25. Yih KW, Brooks DR, Lett SM, Jumaan AO, Zhang Z, Clements KM, et al. The incidence of varicella and herpes zoster in Massachussets as measured by the Behavorial Risk factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003. BMC Public Health 2005; 5:68 Accessible sur : http://www.biomedcentral.com/1471-2458/5/68 Dernier accès 17 septembre 2008.
26. Goldman G.S. Incidence of herpes zoster among children and adolescents in a community with moderate varicella vaccination coverage. Vaccine 21 (2003) 4243-4249
27. Goldman G.S. Universal varicella vaccination: efficacy trends and effect on herpes zoster. Intern J Toxicol 24 (2005) 205-213
28. Varicella Active Surveillance Project (VASP). Statistics and Surveillance. Accessible sur : http://www.cdc.gov/vaccines/stats-surv/vasp/default.htm. Dernier accès 17 septembre 2008.
29. Jumaan A.O., Yu O., Jackson L.A., Bohlke K., Galil K., and Seward J.F. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992-2002. J Infect Dis 191 (2005) 2002-2007
30. Insinga R.P., Itzler R.F., Pelissier J.M., Saddier P., and Nikas A.A. The incidence of herpes zoster in a United States administrative database. J Gen Intern Med 20 (2005) 748-753
31. Edmunds W.J., and Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. J Infect 44 (2002) 211-219
32. Garnett G.P., and Grenfell B.T. The epidemiology of varicella-zoster virus infections: a mathematical model. Epidemiol Infect 108 (1992) 495-511
33. Garnett G.P., and Grenfell B.T. The epidemiology of varicella-zoster virus infections: the influence of varicella on the prevalence of herpes zoster. Epidemiol Infect 108 (1992) 513-528
34. Garnett G.P., and Ferguson N.M. Predicting the effect of varicella vaccine on subsequent cases of zoster and varicella. Med Virol 6 (1996) 151-161
35. Schuette M.C., and Hethcote H.W. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol 61 (1999) 1031-1064
36. Brisson M., Edmunds W.J., Gay N.J., Law B., and De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125 (2000) 651-669
37. Ferguson N.M., Anderson R.M., and Garnett G.P. Mass vaccination to control chickenpox: the influence of zoster. Proc Natl Acad Sci U S A 93 (1996) 7231-7235
38. Halloran M.E., Cochi S.L., Lieu T.A., Wharton M., and Fehrs L. Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 140 (1994) 81-104
39. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127 (2001) 305-314
40. Gidding H.F., Brisson M., Macintyre C.R., and Burgess M.A. Modelling the impact of vaccination on the epidemiology of varicella zoster virus in Australia. Aust N Z J Public Health 29 (2005) 544-551
41. Breuer J. Live attenuated vaccine for the prevention of varicella-zoster virus infection: does it work, is it safe and do we really need it in the UK?. J Med Microbiol 52 (2003) 1-3
42. Davis M.M. Successes and remaining challenges after 10 years of varicella vaccination in the USA. Expert Rev Vaccines 5 (2006) 295-302
43. Jumaan A, Schmid DS, Gargiullo P, Seward J. Letter to the editor. Vaccine 2004; 22:3228-31.
44. Patrick D. Prevention strategies: experience of varicella vaccination programmes. Herpes 14 Suppl. 2 (2007) 48-51
45. Wagenpfeil S., Neiss A., and Wutzler P. Effects of varicella vaccination on herpes zoster incidence. Clin Microbiol Infect 10 (2004) 954-960
46. Whitley R.J. Changing dynamics of varicella-zoster virus infections in the 21st century: the impact of vaccination. J Infect Dis 191 (2005) 1999-2001
47. Farlow A. Childhood immunisation for varicella zoster virus. Universal adoption depends on science, politics, and society's attitude to risk. Br Med J 337 (2008) 419-420
48. Asano Y. Varicella vaccine: the japanese experience. J Infect Dis 174 Suppl. 3 (1996) S310-S313
49. Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D. Le fardeau de la varicelle et du zona en Colombie-Britannique, 1994 à 2003 : évaluation de base préalable à la vaccination universelle. Relevé des Maladies Transmissibles du Canada 2007; 33:1-15. Accessible sur : http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/rm3312a-fra.php. Dernier accès 17 septembre 2008.
50. Lowe G.L., Salmon R.L., Thomas D.R.H., and Evans M.R. Declining incidence of chickenpox in the absence of universal childhood immunisation. Arch Dis Child 89 (2004) 966-969
51. Russell M.L., Schopflocher D.P., Svenson L., and Virani S.N. Secular trends in the epidemiology of shingles in Alberta. Epidemiol Infect 135 (2007) 908-913
52. Bonmarin I., Santa-Olalla P., and Lévy-Bruhl D. Modélisation de l'impact de la vaccination sur l'épidémiologie de la varicelle et du zona. Rev Epidemiol Sante Publique 56 (2008) 323-331